Comparing Mekinist vs Nivolumab
Mekinist (trametinib) | Nivolumab |
|
---|
Mekinist (trametinib) | Nivolumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Melanoma - Metastatic, Low-Grade Glioma, Non Small Cell Lung Cancer, Solid Tumors, Thyroid Cancer. Mekinist may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Head and Neck Cancer, Esophageal Carcinoma, Hepatocellular Carcinoma, Colorectal Cancer, Gastric Cancer, Hodgkin's Lymphoma, Malignant Pleural Mesothelioma, Melanoma, Melanoma -... View more |
Related suggestions Melanoma, Metastatic
Popular comparisons
|
|||||||
More about Mekinist (trametinib) | More about Nivolumab | ||||||||
Ratings & Reviews | |||||||||
Mekinist has an average rating of 7.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Nivolumab has an average rating of 5.9 out of 10 from a total of 142 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Mekinist side effects |
View all Nivolumab side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Mekinist prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Opdivo | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
115.2 hours |
640.8 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 33 drugs are known to interact with Mekinist:
|
A total of 595 drugs are known to interact with Nivolumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
May 29, 2013 |
December 22, 2014 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Yervoy
Yervoy (ipilimumab) is a cancer treatment used for lung cancer, melanoma, renal cell carcinoma ...
Mektovi
Mektovi (binimetinib) is an oral kinase inhibitor that may be used in combination with encorafenib ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Ipilimumab
ipilimumab (Yervoy) is an immunotherapy used for melanoma, renal cell carcinoma, non-small cell ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.